Given such findings, we hypothesized whether hsa‐miR‐29a‐5p is a BC biomarker; our findings showed that the expression of this miRNA increased in tumor samples (especially in advanced TNM stages, videlicet stage III) and also in HER‐2 positive cells. This evidence concerns the gene ERBB2 and neoplasm.